World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
14809
World Ranking
3687
National Ranking
25

Ron N. Apte publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ron N. Apte sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 156 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ron N. Apte D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ron N. Apte sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ron N. Apte is affiliated with Ben-Gurion University of the Negev in Israel, focusing their research primarily on immunology and medicine. Their work extensively covers various aspects of immune cell function, immunotherapy, and cancer immunotherapy.

The main fields of study for Apte include Immunology and Microbiology with 13 publications, alongside Medicine with 9 publications. Subfields include Immunology, Molecular Biology, Oncology, Food Science, and Biological Psychiatry.

Apte's research investigates several key topics, including:

  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • IL-33, ST2, and ILC Pathways
  • Gut microbiota and health
  • Probiotics and Fermented Foods
  • Tryptophan and brain disorders

The scientist has contributed to a number of academic papers published in a variety of scientific journals. Notable recent papers include:

  • Pathogenetic role and clinical significance of interleukin-1β in cancer, 2022, Immunology
  • Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity, 2021, Scientific Reports
  • Subcapsular Sinus Macrophages Promote Melanoma Metastasis to the Sentinel Lymph Nodes via an IL1α-STAT3 Axis, 2022, Cancer Immunology Research
  • Interleukin-1α dependent survival of cardiac fibroblasts is associated with StAR/STARD1 expression and improved cardiac remodeling and function after myocardial infarction, 2020, Journal of Molecular and Cellular Cardiology
  • Tumor Cell-Associated IL-1α Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune Microenvironment, 2024, International Journal of Molecular Sciences

Regarding frequent publication venues, Apte's work has appeared in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Immunology
  • Scientific Reports
  • Cancer Immunology Research
  • International Journal of Molecular Sciences

Collaborations are a notable aspect of this scientist's career. Frequent co-authors include:

  • Elena Voronov (11 coauthored publications)
  • Marina Bersudsky (6 coauthored publications)
  • Omry Koren (4 coauthored publications)
  • Aner Ottolenghi (3 coauthored publications)
  • Mathumathi Krishnamohan (3 coauthored publications)

Ron N. Apte's research contributions provide insights into immunological mechanisms relevant to cancer biology, autoimmune conditions, and immune system regulation, with interdisciplinary applications spanning molecular biology, oncology, and microbiology.

Best Publications

  • IL-1 is required for tumor invasiveness and angiogenesis

    Elena Voronov;Dror S. Shouval;Yakov Krelin;Emanuela Cagnano

  • The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions.

    Ron N. Apte;Shahar Dotan;Moshe Elkabets;Malka R. White

  • IL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation

    Peleg Rider;Yaron Carmi;Ofer Guttman;Alex Braiman

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription.

    Ariel Werman;Rachel Werman-Venkert;Rosalyn White;Jae-Kwon Lee

  • Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation

    Idan Cohen;Peleg Rider;Yaron Carmi;Alex Braiman

  • Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation

    Irena Kaplanov;Yaron Carmi;Rachel Kornetsky;Avishai Shemesh

  • CD11b+/Gr-1+ Immature Myeloid Cells Mediate Suppression of T Cells in Mice Bearing Tumors of IL-1β-Secreting Cells

    Xiaoping Song;Yakov Krelin;Tatyana Dvorkin;Olle Bjorkdahl

  • Interleukin-1β–Driven Inflammation Promotes the Development and Invasiveness of Chemical Carcinogen–Induced Tumors

    Yakov Krelin;Elena Voronov;Shahar Dotan;Moshe Elkabets

  • IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.

    Moshe Elkabets;Vera S. G. Ribeiro;Vera S. G. Ribeiro;Charles A. Dinarello;Suzanne Ostrand-Rosenberg

  • Lack of Interleukin-1α or Interleukin-1β Inhibits Transformation of Steatosis to Steatohepatitis and Liver Fibrosis in Hypercholesterolemic Mice

    Yehuda Kamari;Aviv Shaish;Einav Vax;Einav Vax;Shay Shemesh;Shay Shemesh

  • Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?

    Ron N. Apte;Elena Voronov

  • Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice

    Marina Bersudsky;Lotem Luski;Daniel Fishman;Rosalyn M White

  • Cytokine involvement in oocytes and early embryos.

    Mati Zolti;Zion Ben-Rafael;Ruth Meirom;Mordechai Shemesh

  • The Role of Macrophage-Derived IL-1 in Induction and Maintenance of Angiogenesis

    Yaron Carmi;Elena Voronov;Shahar Dotan;Nitza Lahat

  • Interleukin-1--a major pleiotropic cytokine in tumor-host interactions.

    Ron N Apte;Elena Voronov

  • Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour–host interactions

    Ron N. Apte;Yakov Krelin;Xiaoping Song;Shahar Dotan

  • The role IL-1 in tumor-mediated angiogenesis.

    Elena Voronov;Yaron Carmi;Yaron Carmi;Ron Nathan Apte

  • The Role of IL-1β in the Early Tumor Cell–Induced Angiogenic Response

    Yaron Carmi;Shahar Dotan;Peleg Rider;Irena Kaplanov

  • Monocytes-macrophages that express α-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow.

    Aya Ludin;Tomer Itkin;Shiri Gur-Cohen;Alexander Mildner

Frequent Co-Authors

Elena Voronov
Elena Voronov Ben-Gurion University of the Negev
Charles A. Dinarello
Charles A. Dinarello University of Colorado Anschutz Medical Campus
Shraga Segal
Shraga Segal Ben-Gurion University of the Negev
Margot Zöller
Margot Zöller Heidelberg University
Dror Harats
Dror Harats Sheba Medical Center
Mahmoud Huleihel
Mahmoud Huleihel Ben-Gurion University of the Negev
Angel Porgador
Angel Porgador Ben-Gurion University of the Negev
Edna Mozes
Edna Mozes Weizmann Institute of Science
Yoichiro Iwakura
Yoichiro Iwakura Tokyo University of Science
Roland S. Liblau
Roland S. Liblau Federal University of Toulouse Midi-Pyrénées

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens numerous doors in healthcare and research, but many students also explore related online degrees to broaden their opportunities. For those seeking faster routes into nursing, 12-month accelerated nursing programs offer a practical option for quickly gaining essential skills and licensure.

Entry-level healthcare professionals can consider lpn programs easy to get into, which provide foundational knowledge and hands-on patient care experience, creating a strong base for those interested in immunology-related nursing roles.

Advancing further, many immunology students find value in pursuing advanced practice roles. The easiest nurse practitioner program pathways online help simplify the transition to these in-demand positions, emphasizing both flexibility and quality education.

For those drawn to mental health and community care, the best programs include specialties like psychiatric-mental health. Exploring the best pmhnp programs ensures access to excellent clinical placements critical for hands-on experience in this vital field.

Best Scientists Citing Ron N. Apte

Trending Scientists

Recently Published Articles